MNPR - Monopar Therapeutics added to Russell 3000 and 2000 indexes, stock up 15% June, 03 2025 07:10 AM Monopar Therapeutics Inc. 2025-06-03 07:10:33 ET More on Monopar Therapeutics Monopar a new overweight at Piper Sandler on rare disease asset Seeking Alpha’s Quant Rating on Monopar Therapeutics Historical earnings data for Monopar Therapeutics Financial information for Monopar Therapeutics For further details see: Monopar Therapeutics added to Russell 3000 and 2000 indexes, stock up 15%